Gaceta Mexicana de Oncología Template
Write in a clean editor, then format for Gaceta Mexicana de Oncología in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Gaceta Mexicana de Oncología format
Gaceta Mexicana de Oncología is a peer-reviewed journal published by Elsevier, covering Cancer Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Breast Cancer Treatment Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Gaceta Mexicana de Oncología 12 (2023) 45–58.
Formats any DOI in Gaceta Mexicana de Oncología style. No sign-up. |
| Publishes research in | Cancer Diagnosis and Treatment Sarcoma Diagnosis and Treatment Breast Cancer Treatment Studies Childhood Cancer Survivors' Quality of Life Cancer Treatment and Pharmacology |
| ISSN | 1665-9201 |
| Citation impact (2-yr) | 0.1 |
| h-index | 11 |
| i10-index | 12 |
| Total citations | 799 |
| Open access | Yes |
| Top institutions publishing here | Instituto Nacional de Cancerología |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Gaceta Mexicana de Oncología per year
Citation impact of Gaceta Mexicana de Oncología by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Gaceta Mexicana de Oncología
Breast cancer consists of a heterogeneous group of tumors with different features, biology and treatments. Cancer stem cells (CSCs) have been associated with an aggressive cellular behavior, resistance to chemotherapy and radiotherapy in many types of neoplasms, and a strong correlation between prominin-1 (CD133) expression in cancer stem cells from different types of cancer exist.…
En caso de elegir paclitaxel se recomienda de forma semanal. ** Eribulina demostr incremento en la supervivencia global en pacientes con cncer de mama triple
El cncer de mama es la neoplasia ms comn en mujeres a nivel mundial, al igual que en nuestro pas. Sin embargo, en Mxico, existen diferencias que son importantes de identificar e individualizar para mejorar los desenlaces de las mujeres que padecen esta enfermedad, por lo que el objetivo de esta 8 revisin del consenso…